|
Volumn 51, Issue 1, 1997, Pages 11-15
|
Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIASTHMATIC AGENT;
BECLOMETASONE DIPROPIONATE;
NORFLURANE;
ORGANOFLUORINE DERIVATIVE;
ADULT;
ARTICLE;
ASTHMA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
COUGHING;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG FORMULATION;
DYSPNEA;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SLEEP DISORDER;
WHEEZING;
ADOLESCENT;
AEROSOL PROPELLANTS;
ANALYSIS OF VARIANCE;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
BECLOMETHASONE;
CHLOROFLUOROCARBONS;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
HYDROCARBONS, FLUORINATED;
MALE;
MIDDLE AGED;
PATIENT COMPLIANCE;
THERAPEUTIC EQUIVALENCY;
|
EID: 0030936687
PISSN: 00070947
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (34)
|
References (9)
|